Prognostic impact of thrombocytosis in gastric cancer-A retrospective study
- PMID: 38464547
- PMCID: PMC10919483
- DOI: 10.1097/j.pbj.0000000000000247
Prognostic impact of thrombocytosis in gastric cancer-A retrospective study
Abstract
Background: Solid tumors are a common cause of secondary thrombocytosis, which has been identified as a prognostic factor in various cancers. However, the impact of thrombocytosis on the prognosis of gastric cancer is not yet well defined. The aim of this study was to assess the prevalence and prognostic value of thrombocytosis in patients with gastric cancer.
Methods: This was a retrospective study of patients with gastric carcinoma treated surgically, with curative intent, in our hospital, Centro Hospitalar Vila Nova de Gaia/Espinho, between January 2009 and December 2019. Clinical files were consulted and clinicopathological characteristics were analyzed.
Results: In the present sample (n = 352), the prevalence of pretreatment thrombocytosis was 16.5%. Thrombocytosis was associated with more advanced T stage, greater number of metastatic nodes, and more frequent lymphatic and venous permeation. The presence of thrombocytosis had a negative impact on disease-free survival (hazard ratio [HR] 3.54, 95% confidence interval [CI] 2.35-5.33, P < .001) and overall survival (HR 4.45, 95% CI 2.95-6.71, P < .001).
Conclusions: The presence of pretreatment thrombocytosis had a negative impact on overall survival and disease-free survival and thus could be used as an independent prognostic factor.
Keywords: gastric cancer; thrombocytosis.
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of PBJ-Associação Porto Biomedical/Porto Biomedical Society.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients.Pathol Oncol Res. 2013 Jan;19(1):111-7. doi: 10.1007/s12253-012-9530-z. Epub 2012 May 10. Pathol Oncol Res. 2013. PMID: 22573278
-
Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.Niger J Clin Pract. 2020 Aug;23(8):1141-1147. doi: 10.4103/njcp.njcp_134_19. Niger J Clin Pract. 2020. PMID: 32788493 Free PMC article.
-
Prognostic Impact of Increased Perioperative Platelet Count in Gastric Cancer Patients.J Surg Res. 2019 Oct;242:296-303. doi: 10.1016/j.jss.2019.04.052. Epub 2019 May 21. J Surg Res. 2019. PMID: 31125843
-
Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis.World J Surg Oncol. 2019 Aug 2;17(1):132. doi: 10.1186/s12957-019-1676-7. World J Surg Oncol. 2019. PMID: 31375109 Free PMC article.
-
Thrombocytosis predicts poor prognosis of Asian patients with colorectal cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Sep 2;101(35):e30275. doi: 10.1097/MD.0000000000030275. Medicine (Baltimore). 2022. PMID: 36107503 Free PMC article.
References
-
- Oh SE, Seo JE, An JY, et al. . Prognostic impact of increased perioperative platelet count in gastric cancer patients. J Surg Res. 2019;242:296–303. - PubMed
-
- Baranyai Z, Jósa V, Tóth A, et al. . Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets. 2016;27(4):269–75. - PubMed
-
- Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer. 2012;130(12):2747–60. - PubMed
LinkOut - more resources
Full Text Sources